JP2008518995A5 - - Google Patents

Download PDF

Info

Publication number
JP2008518995A5
JP2008518995A5 JP2007539535A JP2007539535A JP2008518995A5 JP 2008518995 A5 JP2008518995 A5 JP 2008518995A5 JP 2007539535 A JP2007539535 A JP 2007539535A JP 2007539535 A JP2007539535 A JP 2007539535A JP 2008518995 A5 JP2008518995 A5 JP 2008518995A5
Authority
JP
Japan
Prior art keywords
observed
angle
relative peak
predicted
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007539535A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008518995A (ja
JP5057986B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/011789 external-priority patent/WO2006048296A1/en
Publication of JP2008518995A publication Critical patent/JP2008518995A/ja
Publication of JP2008518995A5 publication Critical patent/JP2008518995A5/ja
Application granted granted Critical
Publication of JP5057986B2 publication Critical patent/JP5057986B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007539535A 2004-11-05 2005-11-03 有機化合物 Expired - Lifetime JP5057986B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62534304P 2004-11-05 2004-11-05
US60/625,343 2004-11-05
US64213105P 2005-01-07 2005-01-07
US60/642,131 2005-01-07
PCT/EP2005/011789 WO2006048296A1 (en) 2004-11-05 2005-11-03 Organic compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012109447A Division JP5701246B2 (ja) 2004-11-05 2012-05-11 有機化合物

Publications (3)

Publication Number Publication Date
JP2008518995A JP2008518995A (ja) 2008-06-05
JP2008518995A5 true JP2008518995A5 (enExample) 2008-12-25
JP5057986B2 JP5057986B2 (ja) 2012-10-24

Family

ID=35501294

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007539535A Expired - Lifetime JP5057986B2 (ja) 2004-11-05 2005-11-03 有機化合物
JP2012109447A Expired - Lifetime JP5701246B2 (ja) 2004-11-05 2012-05-11 有機化合物
JP2015003634A Withdrawn JP2015063569A (ja) 2004-11-05 2015-01-09 有機化合物
JP2017004320A Pending JP2017061578A (ja) 2004-11-05 2017-01-13 有機化合物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2012109447A Expired - Lifetime JP5701246B2 (ja) 2004-11-05 2012-05-11 有機化合物
JP2015003634A Withdrawn JP2015063569A (ja) 2004-11-05 2015-01-09 有機化合物
JP2017004320A Pending JP2017061578A (ja) 2004-11-05 2017-01-13 有機化合物

Country Status (31)

Country Link
US (2) US8198435B2 (enExample)
EP (3) EP1812448B1 (enExample)
JP (4) JP5057986B2 (enExample)
KR (3) KR101333851B1 (enExample)
CN (2) CN102993213A (enExample)
AR (1) AR052322A1 (enExample)
AU (2) AU2005300693B2 (enExample)
BR (1) BRPI0517689A (enExample)
CA (1) CA2584911C (enExample)
CY (1) CY1113059T1 (enExample)
DK (1) DK1812448T3 (enExample)
EC (1) ECSP12007431A (enExample)
ES (1) ES2388142T3 (enExample)
GT (1) GT200500311A (enExample)
HK (1) HK1211587A1 (enExample)
HR (1) HRP20120652T1 (enExample)
IL (3) IL182691A (enExample)
JO (1) JO2897B1 (enExample)
MA (1) MA29033B1 (enExample)
MX (2) MX346525B (enExample)
MY (2) MY147404A (enExample)
NO (2) NO338960B1 (enExample)
NZ (3) NZ599033A (enExample)
PE (3) PE20130377A1 (enExample)
PL (1) PL1812448T3 (enExample)
PT (1) PT1812448E (enExample)
RU (2) RU2394038C2 (enExample)
SI (1) SI1812448T1 (enExample)
TN (1) TNSN07165A1 (enExample)
TW (4) TWI530500B (enExample)
WO (1) WO2006048296A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101462693B1 (ko) * 2006-08-16 2014-11-17 노파르티스 아게 고도 결정질 치료용 화합물의 고체 분산체 제조 방법
EP2327706A1 (en) * 2009-11-30 2011-06-01 Novartis AG Polymorphous forms III and IV of N-benzoyl-staurosporine
KR20160008267A (ko) 2014-07-14 2016-01-22 주식회사 윈스 네트워크 기반 영상감시체계에서의 사용자 행위 분석 시스템
EP3592749A1 (en) * 2017-03-06 2020-01-15 Teva Pharmaceutical Works Ltd. Solid state forms of midostaurin
WO2019215759A1 (en) * 2018-05-09 2019-11-14 Alaparthi Lakshmi Prasad An improved process for preparation of midostaurin
IT201900004729A1 (it) 2019-03-29 2020-09-29 Procos Spa Processo per la preparazione di midostaurina ad elevato grado di purezza
US20220242880A1 (en) * 2019-06-24 2022-08-04 Dr. Reddy?s Laboratories Limited Process for preparation of midostaurin
IT201900014346A1 (it) * 2019-08-08 2021-02-08 Procos Spa Processo per la preparazione di midostaurina amorfa con un basso contenuto di solvente organico residuo
IT202000004291A1 (it) 2020-03-02 2021-09-02 Indena Spa Processo per la purificazione di alcaloidi indolo carbazolici
CN111393454A (zh) * 2020-05-07 2020-07-10 奥锐特药业(天津)有限公司 米哚妥林的新晶型及其制备方法
CN115124551B (zh) * 2021-03-24 2024-04-30 奥锐特药业(天津)有限公司 一种高纯度米哚妥林的制备方法
WO2023205504A1 (en) * 2022-04-22 2023-10-26 Rutgers, The State University Of New Jersey Formulations and methods for treating epidermolysis bullosa simplex and related conditions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5373501A (en) * 1976-12-11 1978-06-30 Kitasato Inst Novel antibiotics amm2282 and process for preparing same
JPS60185719A (ja) 1984-03-06 1985-09-21 Ajinomoto Co Inc 抗腫瘍剤
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
US5073633A (en) * 1989-03-23 1991-12-17 Bristol-Myers Company BMY-41950 antitumor antibiotic
US5096330A (en) * 1990-06-21 1992-03-17 M-B-W Inc. Pitch control mechanism for a surface finishing machine
JPH05247055A (ja) * 1992-03-03 1993-09-24 Meiji Seika Kaisha Ltd スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤
JPH05247955A (ja) 1992-03-06 1993-09-24 Taisei Corp 擁壁の施工方法
US5344926A (en) 1992-06-22 1994-09-06 Kyowa Hakko Kogyo Co., Ltd. Process for producing staurosporine derivatives
WO1995032975A1 (en) * 1994-06-01 1995-12-07 Ciba-Geigy Ag Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
RU2191175C2 (ru) * 1995-12-11 2002-10-20 Сефалон, Инкорпорейтед Конденсированные изоиндолоны в качестве ингибиторов протеинкиназы с
BR9917475B1 (pt) * 1999-08-30 2013-07-23 processo para a manufatura de compostos, e, modificação do processo.
CA2439097C (en) 2001-03-26 2010-10-12 Novartis Ag Pharmaceutical compositions
KR100407758B1 (ko) * 2001-08-27 2003-12-01 씨제이 주식회사 스타틴의 제조에 있어서 락톤화 방법
WO2004094645A1 (en) * 2003-04-22 2004-11-04 Lonza Ag Process for the recovery of staurosporine from a fermentation broth

Similar Documents

Publication Publication Date Title
IL190805A0 (en) Antineoplastic combinations with mtor inhibitor, herceptin and/or hki-272
IL186260A0 (en) Alunite compound particle, process for producing the same and use thereof
LTC2100614I2 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
ATE553134T1 (de) Strahlungsbeugungsfarbmittel
EP1958763A4 (en) ALUMINUM ALLOY RESIN COMPOSITE AND METHOD OF MANUFACTURING THEREOF
EP1875534A4 (en) PRECURSOR INFILTRATION AND COATING PROCESS
DE602006019852D1 (de) Verriegelungsspannfutter
JP2008518995A5 (enExample)
FI20050770L (fi) Todentaminen turvakäytännön yhteydessä
DE602006008312D1 (de) Mesostrukturiertes material mit hohem aluminiumgehalt
ATE501056T1 (de) Fälschungssicherer verschluss
DE602006008523D1 (de) Sicherungs- und Klemmwerkzeug
EP1877342A4 (en) PROCESSES FOR PREPARING CHALCOPYRITE COMPOUNDS AND OTHER INORGANIC COMPOUNDS
SI1926476T1 (sl) Amorfne trdne disperzije 7-kloro-N,N,5-trimetil-4-okso-3-fenil-3,5- dihidro-4H-piridazino/4,5-b/indol-1-acetamida
NL1031627A1 (nl) Acylaminobicyclische heteroaromatische verbindingen en toepassingen daarvan.
ZA200805382B (en) Keratin-binding effector molecules, and method for the production thereof
EP1867623A4 (en) Terephthalic derivatives, tetrahalothiophenyl derivatives and processes for their preparation
ZA200803775B (en) Antineoplastic combinations with mTOR inhibitor, herceptin, and/or HKI-272
PT1783105E (pt) Composição de argamassa, seu processo de preparação e sua utilização
DE502006004636D1 (de) Verstellvorrichtung zur Drehrichtungsumkehr
FR2893654B1 (fr) Serrure de securite
DE602006004566D1 (de) Substituierte pyrrole, zusammensetzungen, die dieshre verwendung
DE602006007969D1 (de) Zusammensetzungen zur verzögerten energiefreisetzung
DE602005025621D1 (de) Mechanismus zur bildung eines webfachs und mit dem webfach ausgerüstete webmaschine
FI20055090A0 (fi) Lukitusväline